Surgical Therapy of Hepatocellular Carcinoma: State of the Art Liver Resection by Davakis, Spyridon et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







Surgical Therapy of Hepatocellular 
Carcinoma: State of the Art Liver 
Resection
Spyridon Davakis, Michail Vailas, Alexandros Kozadinos, 
Panagiotis Sakarellos, Anastasia Karampa, Dimitrios Korkolis, 
Georgios Glantzounis, Alexandros Papalampros  
and Evangelos Felekouras
Abstract
Hepatocellular carcinoma (HCC) represents the third most common cause 
of cancer-related death, showing incremental growth rates throughout the last 
decades. HCC requires multidisciplinary approach in a group of patients suffering 
from underlying chronic liver disease, usually in the setting of cirrhosis. The main-
stay of treatment in resectable cases is surgery, with anatomic and non-anatomic 
liver resections widely implemented, as well as liver transplantation in well-selected 
individuals. Nowadays, there is a variety of liver parenchyma transection devices 
used by hepatobiliary surgeons in specialized centers, which has significantly 
improved postoperative outcomes in HCC patients. Therefore, hepatectomy is 
considered safe and feasible and should be the main therapeutic option for HCC 
patients, candidates for resection. Liver resection utilizing cavitron ultrasonic 
aspirator in combination with bipolar radiofrequency ablation is safe and effective 
for the treatment of HCC with favorable clinical and oncological outcomes.
Keywords: Hepatocellular Carcinoma, cirrhosis, surgical treatment, liver resection, 
technique, outcomes
1. Introduction
The evolution and development of the surgical techniques utilized during liver 
resection for Hepatocellular Carcinoma (HCC) are largely an account of the efforts 
to minimize bleeding during liver parenchymal transection. There is a close relation 
between blood loss and unfavorable outcomes during liver resection. The modern 
era liver transection techniques are based on notable advances in solid organ 
imaging (Computed Tomography, Magnetic Resonance Imaging, Ultrasound), 
vastly improved anesthetic management, enhanced knowledge of segmental liver 
anatomy as described by Couinaud [1], refined surgical techniques with notable 
appreciation of the functional reserve of the liver remnant, as well as the liver 
regeneration process [2].
Major hepatectomies had been associated with mortality rates of up to 20% 
during 1990’s, and excessive bleeding was an important and common cause of 
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operative mortality [3]. However, liver resection can now be accomplished with 
mortality rates of less than 2% in most specialized hepato-pancreato-biliary (HPB) 
centers [4].
While better patient selection and improved assessment of functional liver 
remnant are important factors [5], reduced blood loss and the diminishing need for 
blood transfusion have been additional reasons for improved peri-operative out-
come [6]. Other advances in operative technique, including improved delineation 
of the optimal transection plane with intra-operative ultrasound [7] and the benefit 
of intermittent inflow occlusion, have also contributed to a reduction in blood loss 
during major liver resections [8].
The technique of parenchymal transection in hepatic resection has been a topic 
of great debate for decades worldwide. Finger fraction and clamp-crush techniques 
have been presented more than fifty years ago and have established as standard 
approach for liver transection. Significant technological improvements over the past 
thirty years have led to utilization and adoption of specific surgical instruments 
and devices for liver transection, such as radiofrequency ablation (RF), ultrasonic 
cavitron aspirators (Cusa), bipolar sealers (Aquamantis), bipolar energy devices 
(Ligasure), ultrasonic dissectors (Harmonic), water jet and Tissue link, amongst 
others [5, 9, 10].
2. Prehistory of liver surgery (1886–1950)
Liver surgery has been a huge chapter in modern surgery and more ground-
breaking evolution is still yet to come. Its meaningful to review the beginning of 
hepatic resections that were reported in the 19th century and follow the journey up 
to modern times and the techniques that are used today.
The first hepatic operation was done and reported back in 1886 by Lius. 
He achieved the first partial hepatectomy to a patient with a hepatic adenoma. 
Reportedly, the use of sharp instruments and Paquelins cautery were utilized for 
this operation. Unfortunately, post -op hemorrhage was uncontrollable, and the 
patient died. It is interesting to note that even back in the 19th century, the use of 
cautery by liquid means was prominent [11].
Following the pioneer of hepatic surgery, Bruns (1888- metastatic liver cancer) 
and von Eiselberg (1893-hemangioma) attempted hepatectomies. Furthermore, 
Keen described in 1899 a liver wedge resection in 3 of his patients [12]. In 1891 
Lucke achieved the first successful left lobar liver carcinoma excision [13]. In 1908 
a very famous physician, whose technique is predominantly used around the world 
today in hepatic operations, Doctor Pringle, performed abdominal operation in 
4 patients with hepatic bleeding of traumatic cause. He managed to control the 
hemorrhage by clamping the hepatic vein and artery. Only 1 patient survived after 
this maneuver [14].
In 1911 Wendel reported the first successful right hepatectomy in a 44-year-old 
woman. He followed the instructions of Cantlie’s functional anatomy in detail. 
Primarily hilar dissection and ligation of right hepatic artery and right hepatic 
duct was achieved, and furthermore dissection through the quite avascular plane 
described by Cantlie was performed. Only a year later, Lin applied a new technique. 
The goal was to resect and destroy liver parenchyma with minimal damage to ves-
sels. This concept will be followed over the years up to present times. The use of the 
“finger fracture method” served such purpose by resecting parenchyma and leaving 
vessels undamaged and ready for ligation [15].
As years passed by, it is more evident that 5 historic factors from 1950 and 
onwards played a role and shaped liver surgery, especially for hepatocellular 
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carcinoma, as we know it today. Primarily the ability of bleeding control in liver 
trauma gave confidence to surgeons to proceed in large resections. Secondly, the 
control of blood supply and drainage of the liver to a more specific level rather than 
gross ligation of large vessels. The advance in supportive medicine such in fluid 
balance, adequate anesthesia, respiratory support, and hemodynamics played a key 
role in a successful operation. Following these, the advancement of imaging modali-
ties and the multimodality team approach in treatment algorithm of HCC.
3. Multi-modality treatment of HCC
HCC remains the leading cause of cancer related mortality worldwide [16]. 
Hepatitis C is the most frequent risk factor for HCC in the Western world. On the 
other hand, chronic hepatitis B infection is the main risk factor in East Asia and 
sub-Saharan Africa, where incidence rates of HCC are the highest [17]. The MDT 
can establish patient access to well-established, as well as new multimodality 
therapies, consulting with all the involved specialists. These emerging therapeutic 
algorithms have led to review and updates of the treatment management in primary 
hepatobiliary cancers. Surgery remains the most-effective curative option for all 
primary hepatobiliary cancers; however, not all patients are good surgical candi-
dates at the diagnosis, due to advanced disease. The Hepatobiliary MDT is crucial 
for ensuring that other treatment modalities are considered (palliation – best 
supportive care). This approach can optimize patient care, both on curative and 
palliative ways. HCC screening has undoubtedly helped earlier detection of tumors, 
allowing prompt commencement of treatment, positively impact on patients’ 
outcomes [18].
4. Evolution of imaging modalities
Although current management guidelines for HCC do not require biopsy to 
prove the diagnosis, lesions greater than 2 cm on MRI or Computed Tomograph 
Angiography (CTA) scans, with elevated AFP (more than 400 ng/mL) or AFP 
incrising within sequential measurements, do not require pathologic confirmation 
according to the guidelines of the European Association for the Study of the Liver 
(EASL) [19].
According to American Assosiation of Liver Diseases (AASLD) guidelines, 
liver nodules detected on abdominal US, measuring less than 1 cm should be 
re-examined twice a year. If no radiological alteration of the hepatic lesion has 
occurred during a period of up to 2 consecutive years, routine surveillance should 
be considered.
Every suspicious lesion in high-risk population, with suggestive US-findings for 
HCC, should be further studied with additional imaging modalities. This radiol-
ogy workup should include a 4-phase multidetector CT scan or dynamic contrast 
enhanced MRI. If the tumor has all the typical characteristics of HCC, it should be 
treated as HCC. If a liver nodule compatible with HCC is greater 2 cm at the initial 
diagnosis after one dynamic imaging study, biopsy is not mandatory. However, if 
the vascular profile of the lession on imaging studies of a non-cirrhotic patient is 
not compatible with HCC, a second imaging study or biopsy of the lesion should 
be performed to secure the correct diagnosis. If the biopsy is negative for HCC, 
patients should be further surveilled via an abdominal US every 3–6 months, until 
the lession presents enlarged or with altered imaging characteristics. According to 
the guidelines of the Asia-Pacific Association for the Study of the Liver 2010 [20], 
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every liver lesion with non-typical vascular features should be further investigated 
with other modalities, such as endoscopic ultrasound (EUS).
It is well established that contrast-enhanced CT scans and MRI scans can be per-
formed to examine, differentiate, and investigate a liver lesion. HCC has commonly 
a unique imaging array [21]. High arterial-phase contrast uptake followed by rapid 
washout in late phase are common in contrast-enhanced CT and MRI scans; these 
characteristics may not be present in earlier stages or in not well-differentiated 
tumors. Triphasic CTA can identify more lesions; however, in patients with nodular 
cirrhosis, contrast-enhanced MRI should be performed. Tumors sizing between 1 
and 2 cm in cirrhotic patients, should be further studied with triphasic CTA and 
MRI to exclude HCC [22].
5. Anesthesiology management
During the last century, huge technological and medical advance aid surgeons 
to easier define their objective rather carefully and to overcome the shrieks and 
wails of their awake patients as in past times. Anesthesia of modern times came 
of age, so that the operating rooms became well-orchestrated exhibitions of joint 
expertise and support. We can now safely say that all matters are now a concern of 
the anesthetists; they furnished the hemodynamic support for complex operations, 
as liver surgery. Consequently, surgeons were allowed to focus on their meticulous 
procedures.
Matters of special interest are conditions that can cause an elevation of right-side 
cardiac and central venous pressure (CVP), which can significantly increase the risk 
of intra-operative bleeding. Invasive arterial and CVP monitoring allows for better 
hemodynamic control and regular blood sampling. All patients may benefit from 
cardiac output monitoring, enabling greater stability during the cardiovascular 
changes associated with vascular occlusion during hepatic resection. Core tempera-
ture should be monitored and normothermia maintained using warmed-fluids and 
forced warm-air blankets. Intra-operative coagulation profile should be monitored 
and corrected with fresh frozen plasma or/and coagulation factors, as indicated 
from laboratory results. Neuromuscular block should be also monitored [23].
6. Surgical approach
It well established that in patients without impaired underlying liver status 
( cirrhosis), an anatomical resection should be accomplished. Major hepatectomies 
can include up to two-thirds of the functional parenchyma. For cirrhotic patients, 
due to impaired liver regeneration process, resection is generally minimized to 
smaller hepatectomies, to maintain adequate liver function. Hypertrophy of the 
future liver remnant can be achieved with the use of pre-operative portal vein 
embolization (PVE).
One of the most important key factors during liver resection of HCC is the uti-
lization of intra-operative ultrasound (IOUS), to identify tumor location, margins 
and its relation to the inflow and outflow vascular structures. The definition of a 
proper surgical strategy is important not only for achieving an adequate tumor-free 
margin, but also for avoiding inadvertent injuries to major intrahepatic vessels or 
bile duct pedicles during dissection or resection.
Management of hepatic inflow through the portal vein and/or vena cava, and 
hepatic outflow through the hepatic veins, can be routinely performed with control 
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of this vessels. Controlling of the vascular inflow (Pringle maneuver) as an alterna-
tive to total vascular occlusion, has decrease deleterious effects of liver ischemia. 
Ischemic preconditioning of the liver has recently been proposed as a hepato-
protective measure, consisting of application of a brief period of ischemia (10 min) 
and reperfusion (10 min) after which, a prolonged-period of the liver inflow 
occlusion can be safely supported. In a prospective series, comparing major liver 
resections using the Pringle maneuver lasting 30–60 min, an advantage was found 
of ischemic preconditioning in young patients (<60 years), as well as in patients 
with steatosis or cirrhosis. Intermittent Pringle occlusion can be well tolerated by 
cirrhotic patients for up to 60 minutes, and is better tolerated than continuous 
clamping. The use of low CVP (less than 5 mm Hg) is also of great importance.
7. Techniques of liver parenchyma transection for HCC
7.1 Finger fracture technique
Hepatic transection remained a challenge for all surgeons, for more than 
a century. The first scheduled hepatectomy was performed in 1888 from Carl 
Langenbuch [24]. Liver surgery was minimal thus, up to the 20th century, when 
Pringle maneuver was first presented, for bleeding control during emergency 
hepatic resections [14]. Hepatectomy is particularly difficult in cirrhotic liver due 
to the fibrotic nature of liver tissue. The finger fracture technique, the liver tissue 
is fractured and crushed by the thumb and index finger followed by isolating and 
ligating the resistant intrahepatic vascular and ductal structures [15].
7.2 Crash-clamp (Kelly) technique
The finger fracture technique, in which the parenchymal transection is done by 
crushing the parenchyma between the thumb and another finger isolating vessels 
and bile ducts which were ligated and divided, after liver inflow occlusion, was 
afterward improved using a surgical instrument such as the Kelly clamp [25]. Using 
the Kelly clamp technique during hepatic resection of cirrhotic liver with HCC 
can be performed in less operative time, while help obtaining a clearer operative 
field [26].
7.3 Radiofrequency ablation (RFA) assisted technique
RF assisted hepatectomy, for the treatment of hepatocellular carcinoma amongst 
other liver malignancies, was first implemented by Habib’s group at Hammersmith 
Hospital, London, UK [27]. Ever since, RFA has been widely used for the in-situ 
ablation of unresectable liver and other solid organ tumors [28], but it has now been 
incorporated into routine liver resection, being used to create a line of coagulative 
necrosis that can subsequently be divided with a scalpel with relatively little blood 
loss [29]. In recent years, the continuous use and development of RFA ablation in 
liver surgery have produced satisfactory results in the treatment of small HCC. It 
can also block small and medium-sized blood vessels in the liver through thermal 
coagulation, so it has been used in liver resection to reduce bleeding. However, the 
use of this technique remains controversial due to reported perioperative outcomes 
and complications; some studies have reported that radiofrequency-assisted liver 
resection causes severe postoperative liver dysfunction, and the incidence of post-
operative complications is higher than that of simple hepatectomy [30].
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7.4 Cavitron ultrasonic aspirator (CUSA) technique
Cavitron Ultrasonic Surgical Aspirator (CUSA), also known as Ultrasonic 
Dissector, was first popularized by Hodgson et al. in 1979 [31]. The ultrasonic 
waves generate energy to fragment and aspirate parenchymal tissue. Contact of 
the oscillating titanium tip instigate fragmentation of hepatocytes owing to the 
high-water content while, selectively sparing the blood vessels and bile ducts 
because of poor tissue water content. In the liver parenchyma, anatomically, both 
the Glissonean cords as the inflow system and the hepatic veins as the outflow 
system show branching, like a tree. Both systems rise from the dorsal side, where 
they are relatively close to each other, and branch towards the ventral side. Any 
liver resection can become simpler and safer by selectively dissecting in a plane, 
where no Glissonean cord runs, such as an intersegmental plane. When such planes 
are dissected with the CUSA, the hepatic veins, which are relatively thicker and can 
be more easily identified than those that appear when the other parts are divided, 
usually appear in the cutting plane. Further, some thinner branches, which cross 
the cutting plane and flow into the exposed thicker hepatic vein, should be cut at 
the confluence without incurring a split injury [32]. It has been proven that CUSA 
selectively destroys and aspirates parenchyma, leaving vessels and biliary ducts 
almost intact with larger vessels and large intrahepatic bile ducts amenable to liga-
tion or clipping [33].
7.5 Sealing device-assisted technique
The LigaSure Vessel Sealing System (Valleylab, Boulder, CO, USA) is a hemo-
static and dissecting tool, which is able seal blood vessels (up to 7 mm in diameter), 
by denaturing collagen and elastin within the vessel wall and in the surrounding 
connective tissue [34]. LigaSure can be safely applied in any type of liver and 
hepatectomy combined with the crush clamping method.
The Harmonic Scalpel (Ethicon Endo-Surgery, Cincinnati, OH, USA), utilizes 
ultrasonic vibration of two blades causing destruction of hydrogen bonds. This 
disturbance of hydrogen bonds causes protein denaturization coagulating small 
vessels of 3 mm diameter. The parenchyma is then transected with blade movement 
in a saw-like fashion [35].
7.6 Tools for resection
As mentioned above, the techniques used in liver transections were described 
in reports and were widely used. From the finger fracture technique described by 
Lin [15] to the use of the blunt end of a hemostat by Ogilvie [36] and the use of 
the blunt edge of a scalpel by Quattlebaum, a common goal can be perceived. The 
identification of different tissues, parenchyma vs. vessel, via the means of blunt 
dissection. Perseverance of great vessels and following appropriate ligation was the 
main aim of hepatic surgeons to avoid uncontrollable hemorrhage. Avoiding such 
complication could mean avoiding death.
In 1928 the first electrocautery device was invented. The Bovie knife, known 
from its inventors Bovie and Cushing, is the tool of choice up to this day by majority 
of centers when it comes to hemostasis and partial resection of the liver paren-
chyma [37]. A few years later, the need of new and perhaps more effective ways for 
liver surgery was explored.
Another technique that originates from compression characteristics of hemo-
stasis is the hemostatic clamp. During the years, many surgeons have used such 
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clamps. Back in 1960s the first clamp used in liver surgery was described by Stucke 
[38]. Variation of such were seen within the same decade. It needed the efforts of 
Nakayama to reach a newly designed clamp, specific to the liver [39].
8. Our technique
We have been performing liver resection routinely for the past 30 years. The 
first attempt towards a bloodless and uneventful hepatectomy was the formation of 
a proper HPB Unit, formed by specialist surgeons, dedicated anesthetists, ICU beds 
and experienced radiologists (invasive). Gradual implementation and enhance-
ment of the new techniques followed. In the beginning, finger fracture/crash 
clamp technique was performed in all cases of liver resection, with the addition of 
electrocautery and argon beamer as adjuncts. Following that, from the beginning 
of 2000s, we adopted and evolved the RF-assisted liver resections, with favorable 
outcomes during numerous hepatectomies. However, we moved to the two sur-
geons’ technique with newer abdominal retractors (Thompson Liver / Oncology 
System) since 2006; our transection tools have been standardized to implementa-
tion of CUSA for dissection of liver parenchyma and Aquamantis for hemostasis 
(Figures 1 and 2).
For major hepatectomies the ipsilateral major hepatic veins were encircled 
within vessel loops. When an anatomic resection was planned, hilar dissection was 
performed (Figure 3).
The ipsilateral branch of hepatic artery, portal vein, and common bile duct 
were encircled within vessel loops, but not divided, until the parenchymal dissec-
tion reached that point. Hilar dissection was not performed for non-anatomical 
hepatectomy. During major hepatectomies, the ipsilateral hepatic artery, portal vein 
branches and bile duct branches were ligated intra-hepatically during parenchymal 
transection. In addition, for major hepatectomies, the major hepatic veins were 
either suture-ligated and divided or divided using endovascular staplers at the end 
of parenchymal transection (Figures 4–8).
Drains are routinely placed in all patients.
Figure 1. 
Demarcation line using monopolar cautery.
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Anatomic and non-anatomic hepatectomies, wedge resections and liver abla-
tions are routinely performed for the treatment of HCC from our team. Anatomic 
resections are selected in patients with unilobular disease and adequate liver func-
tion. Major hepatectomies include right and left hepatectomies, as well as extended 
right and extended left hepatectomies or trisectionectomies. Non-anatomic 
Figure 2. 
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resections and liver ablation can be performed for smaller lesions, multilobular 
disease, in patients with previous hepatic resection (recurrence) or in cases with 
severely impaired liver function. Parenchymal sparing is crucial for maintaining 
adequate liver remnant post hepatectomy for these patients. In addition, vascular 
reconstructions in cases with vascular infiltration is possible in specific cases, as 
ex-vivo hepatectomy with auto-transplantation in cases of locally advanced/unre-
sectable disease.
Figure 4. 
Dissection of segmental branches.
Figure 5. 
Transection with vascular stapler.
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9. Results
Between January 1st 2010 and January 1st 2021, more than n = 300 consecutive 
hepatectomies were performed in three referral hepatobiliary centers in Greece, 
from affiliated surgeons. Patients included in this study was treated for hepatocellu-
lar carcinoma and were treated with curative intent (hepatectomy). Adult patients 
that underwent elective operations were enrolled. All emergency operations or 
operations for other liver malignancies were excluded.
Figure 6. 
Remaining liver parenchyma post right hepatectomy.
Figure 7. 
Use of hemostatic-fibrin glue and final inspection.
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N = 170 patients underwent liver resection for HCC during the study period. 
Mean age was 75 years (Range: 20–85). There were 115 males and 55 female patients. 
Etiology of liver disease was liver cirrhosis in most cases, due to alcoholic liver 
disease (ALD) (23.5%), hepatitis B (HBV) infection (42.35%), hepatitis C (HBC) 
infection (17.64%) and hepatic steatosis (16.4%). Most of the patients (n = 99, 
55%) were BCLC-A patients, while n = 71 (45%) patients were BCLC-B or BCLC-C 
staged. N = 89 patients (52.35%) passed away during the follow-up. Post-operative 
complications according to Clavien-Dindo classification, were grade I in 54.66%, 
grade II in 24% and III-IV in 17.33% of the cases, respectively. Thirty and 90-day 
mortality rates were 1.13%. Mean length of hospital stay was 17.5 days. Mean OS was 
46.66 months, while mean PFS was 31.56 months. OS figures for 1, 3 and 5 years 
was 87.14%, 64% and 42% respectively.
This data indicates that liver resection for HCC with utilization of the combined 
technique of saline-linked radiofrequency ablation and ultrasonic aspiration, is 
safe and feasible, leading towards bloodless liver resection without the use of vas-
cular occlusion, ensuring that surgical treatment for HCC becomes comparatively 
safer (Figure 8).
Figure 8. 
Right hepatectomy for HCC in a cirrhotic patient.
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9.1 Minimally invasive liver resection
Minimally invasive liver resection is on the rise. However, the majority of 
performed operations are minor or limited resections in highly selected patients, 
from experienced hepato-biliary surgeons. The first laparoscopic liver resection 
was reported in 1991 [40], was referred to excision of peripheral hepatic lesions. 
Anatomic resections such as left lateral hepatectomy were followed thereafter [41]. 
The first series of laparoscopic hepatectomies were published in 1998 by Hüscher 
et al. [42] using totally laparoscopic and hand-assisted (hybrid) approach for  
right-sided liver resections.
Although it has several theoretical advantages, only a small percentage of liver 
resections are performed by minimally invasive surgery. A French national database 
study, published in 2014, presented that only 15% of liver resections were per-
formed through minimally invasive approach [43].
Minor laparoscopic resections in anterolateral segments, as well as left lateral 
sectionectomy are considered the gold-standard approach in the hands of experts 
nowadays [44]. On the other hand, excision of bilateral lesions or lesions in postero-
superior segments or in central locations of the liver (segments 1, 4a, 7, and 8), and 
mostly major hepatectomies are still considered rather challenging. Another key 
factor is the learning curve for minimally invasive liver resection, that can reach up 
to 75 operations [45].
Robot-assisted surgery has been gradually adopted as an alternative to laparos-
copy, mainly in complex and major liver resections [46]. Despite all the potential 
advantages, most of the available evidence present no superiority of robotic assisted 
comparing to laparoscopic liver resections [47].
10. Conclusion
Hepatocellular Carcinoma (HCC) is the most frequent primary liver tumor. 
Well-established risk factors include chronic hepatitis B and C, non-alcoholic liver 
cirrhosis and liver steatosis amongst others, leading to impaired liver function in 
most cases. Surveillance programs and multi-disciplinary team approach aim to 
early diagnosis and effective therapy. Liver resection is the mainstay of treatment 
for HCC. All efforts are made towards bloodless hepatectomies, with adoption of 
newer techniques and evolvement of existing approaches. Laparoscopic or robotic 
liver resection can offer all the advantages of minimally invasive surgery in the 
hands of experts and for specific group of patients. Our technique of liver resection 
for HCC consists of saline-linked radiofrequency ablation and ultrasonic aspiration, 
is safe and feasible, leading towards bloodless liver resection without the use of vas-
cular occlusion, ensuring that surgical treatment for HCC becomes comparatively 
safer in specialized hepatobiliary cancer centers.
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